Top Obesity Research Papers

Overall: A strong phase 3 trial shows exceptionally large weight loss with meaningful improvements in knee pain and sleep-apnea severity, but incomplete safety reporting and real-world access burdens temper its immediate impact.

Overall: This large randomized-trial synthesis is clinically influential and directly applicable to US obesity care, but limited head-to-head comparisons, sparse hard-outcome evidence, increased adverse-event discontinuation, and absent absolute effects temper confidence in the net benefit.

Overall: This large observational study links simple central-adiposity measures to clinically important cardiovascular outcomes, but it does not establish that risk reclassification improves treatment or patient outcomes.

Overall: A large, well-conducted review shows substantial weight loss across several incretin-based therapies, tempered by heterogeneous evidence, limited reporting of broader health outcomes, and frequent gastrointestinal adverse effects.

Overall: This rigorous but small trial found substantial weight loss with semaglutide in a specialized post-bariatric population, with promising clinical relevance tempered by limited patient-outcome data, safety events, and implementation barriers.

Overall: A very large contemporary US cohort links BMI and diabetes with gestational-age-specific stillbirth risk, but its observational design and lack of complete absolute effects or tested delivery strategies limit immediate practice change.

Overall: This prespecified randomized-trial analysis provides credible evidence that semaglutide retains cardiovascular benefit in a primary-care-relevant high-risk subgroup, but absent absolute effects and safety data and reliance on a surrogate liver measure limit its independent practice-changing impact.

Overall: This well-controlled trial suggests that oral orforglipron can preserve weight loss after injectable therapy, but missing absolute weight effects, limited patient-important outcomes, and no active comparator temper its immediate practice-changing value.

Overall: A large, precise cohort provides clinically relevant dietary guidance for menopausal weight management, but observational evidence, self-reported outcomes, and limited novelty constrain practice-changing impact.

Overall: A large and methodologically strong synthesis identifies several effective pharmacologic options for antipsychotic-associated weight gain, but specialist overlap, implementation barriers, and the absence of direct patient-important clinical outcomes limit its impact for routine US primary care.